Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 23Prostatic Neoplasms 9Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 3Fibrosis 3Carcinoma, Intraductal, Noninfiltrating 3Ovarian Neoplasms 2Mouth Neoplasms 2Melanoma 2Lymphedema 2Liver Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Medullary 2Carcinoma, Hepatocellular 2Anatomic Stage I Breast Cancer AJCC v8 2Wilms Tumor 1Uterine Hemorrhage 1Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Nodule 1Thyroid Cancer, Papillary 1Stomatitis 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Somatostatinoma 1Sarcoma, Endometrial Stromal 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Pheochromocytoma 1Pain 1Oropharyngeal Neoplasms 1

Interventions

Capecitabine 4Temozolomide 3Octreotide 3Leucovorin 3Fluorouracil 3Everolimus 3vatalanib 2Trastuzumab 2Streptozocin 2Oxaliplatin 2Doxorubicin 2Bevacizumab 2tipifarnib 1romidepsin 1regorafenib 1pentetreotide 1motesanib diphosphate 1epothilone B 1batifiban 1Thalidomide 1Sorafenib 1Pantoprazole 1Omeprazole 1Irinotecan 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1Gefitinib 1Floxuridine 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastrinoma × High-Energy Shock Waves × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡